Institute of Orthopedics and Traumatology of HCFMUSP
São Paulo, 05403-010, Brazil
NCT Number: NCT00542516
Currently the most use solution to volemic reposition in hip replacement arthroplasty is the crystalloid solution. This trial intends to compare two different volemic replacements: HES and Ringer's lactate. This research has been analyzing hemodynamic parameters and the coagulation status before and after the pre-expansion with the solutions above mentioned.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 4
São Paulo, 05403-010, Brazil
This trial is randomized an blind to the physician who is analyzing the results.It has been select adults; both sex; ASA I and II. These patients must be submitted to hip arthroplasty replacement. The anesthesia technique is single shot spinal anesthesia. Primary endpoint: assessment alternative; technique replacement volemic with HES 130/04. Secondary endpoint: haemostatic abnormalities; blood loss; transfusion blood.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dosage: 30ml/kg; frequency: one time; duration: 60min
Other names: Voluven
Dosage: 30ml/kg; frequency: one time; duration: 60min.After 10ml-kg-h both groups
Time frame: 24 hours
Time frame: 24 hours
Time frame: 24 hours
University of Sao Paulo
Other
Comparison Between Two Techniques of Volemic Expansion in Hip Replacement Arthroplasty: Hydroxyethyl Starch Versus Ringer's Lactate
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01394744
Hip Replacement Arthroplasty
Munich, Bavaria, Germany
View Trial DetailsNCT02162121
Hip Replacement Arthroplasty
Milan, Italy
View Trial DetailsNCT03724058
Hip Replacement Arthroplasty
Hässleholm, Sweden
View Trial Details